In the intestinal epithelium, our laboratory demonstrated that RIP140 inhibited the Wnt/β‐catenin signaling pathway and exerted an antiproliferative activity on CRC cells [27]. This evidence concerns the gene NRIP1 and colorectal carcinoma.